Authors


Malka Niknamfard, PA-C

Latest:

Case Report: Repigmentation of the Lips Using Ruxolitinib

Dive into a complex case report of a 29-year-old African American male patient with Fitzpatrick skin type V with a 6-month reported history of vitiligo on his lips.


Dawn L. Sammons, DO, FAOCD, FAAD

Latest:

Key Takeaways for the Management of Plaque Psoriasis

Experts in dermatology share final thoughts on the treatment of plaque psoriasis and the ever-changing treatment landscape.


Daniela Marino, PhD

Latest:

Cutiss, DenovoSkin Changing the Standard of Burn Care Across the Globe

CEO Daniela Marino, PhD, emphasizes that the Switzlerand based company has received Orphan Drug Designation from the Swissmedic, EMA, and FDA, for its personalized human skin graft.


Kilian Eyerich, MD, PhD

Latest:

Upadacitinib Demonstrates Efficacy in Patients With AD and Head and Neck Involvement

Kilian Eyerich, MD, PhD, shares insights into an EADV 2024 presentation on upadacitinib’s ability to achieve almost total skin clearance in the head and neck regions with minimal effect on quality of life.


Kyle Munz

Latest:

Additional Medicaid Expansion Would Provide Advantages to Patients With Melanoma

During the 2024 American Society of Clinical Oncology annual meeting, a poster highlighted the advantages Medicaid expansion could offer to individuals with melanoma.


George Han, MD, PhD

Latest:

Frontline Forum Part 3: Challenges and Opportunities to Enhance Psoriasis Management

A panel of experts discusses tailoring treatment to patient needs, supporting patients' mental health, and considering future directions.


DiAnne Davis, MD, FAAD

Latest:

Dermatology Times in France: What La Roche-Posay Products Dermatologists Recommend for Eczema, Acne

Dermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.


Anna Bar, MD, FACMS

Latest:

Mohs for the Nose: Reconstruction Session Sneak Peek With Anna Bar, MD, FACMS

Bar will share insight on foldover interpolated flaps for full thickness of nasal defects.


Briana Contreras

Latest:

New, Difficult-to-Treat Fungal Skin Infections Are Emerging, Clinicians Warn

Two new forms of Trichophyton mentagrophytes type VII and Trichophyton indotineae are emerging, according to a new report.


Jeremy Brauer, MD

Latest:

Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook

Brauer’s textbook can be purchased through Amazon and Barnes & Noble.


Oriana Lerner

Latest:

Can Supplements Effectively Manage Hair Loss?

Data presented at the American Academy of Dermatology 2022 Annual Meeting shows what supplements can and cannot manage alopecia areata.


Alan Irvine, MD, DSc

Latest:

Assessing Quality of Life and AAD Research Considerations

Alan Irvine, MD, DSc, shares insights on the impact of ruxolitinib on quality of life in pediatric patients and 2024 AAD research presentations to take into consideration.


Sachin Shridharani, MD

Latest:

Insights Into Positive Decision for Galderma's RelabotulinumtoxinA in Europe

Sachin Shridharani, MD, FACS, discusses the READY-1 and READY-2 clinical trials and positive support for Relfydess.


Marc Hurlbert, PhD

Latest:

Striving for Melanoma Advancements With the Melanoma Research Alliance

Marc Hurlbert, PhD, discusses how the Melanoma Research Alliance works with dermatology clinicians to provide fundings and resources for melanoma research.


Michael Payette, MD, MBA, FAAD

Latest:

Discussion of Traditional and Novel GPP Treatment Modalities

An expert in dermatology shares his insights into the management considerations with traditionally utilized treatments for generalized pustular psoriasis and discusses the impact of a recent approval in this space.


Heidi Moawad, MD

Latest:

What You Need to Know About Mentoring Doctors

Defining the goals of the mentoring relationship can be useful to clarify expectations.


Kathryn Schlenker, DO

Latest:

Best Communication Practices to Explain Palliative Care Plans

Katie Schlenker, DO, emphasizes the importance of empathy during tough conversations with skin cancer patients with few to no treatment options left.


Christine Pham, PharmD

Latest:

Clascoterone cream 1% targets androgen receptors

The topical cream is the first acne drug with a new mechanism of action to win FDA approval in the last 40 years.


Tracee Blackburn, PA-C

Latest:

Tracee Blackburn, PA-C: Gut Health for Healthy Skin

Blackburn presented integrative medicine pearls on gut and hormone health at the 2024 Diversity in Dermatology meeting.


Sara M. Wilchowski, DMSc, MPAS, PA-C

Latest:

From Clinic to Industry: Insights Into the MSL Role and PA Advocacy

At the 2024 SDPA Fall Conference, Sara Wilchowski, DMSc, MPAS, PA-C, highlighted the challenges and rewards of transitioning to industry roles, the impact of “Insta-Tok” on patient care, and the evolving landscape of dermatology.


Rocco Serrao, MD

Latest:

Rocco Serrao, MD Looks Ahead to Bimekizumab’s Approval

We had the chance to catch up with Serrao before he took the stage and he explained why dermatology clinicians should keep their eyes on bimekizumab’s data and shared opportunities for further research.


Nichole Tucker

Latest:

LEAP-010 Study Discontinued for Patients with PD-L1-Expressing HNSCC

A coprimary end point in the phase 3 LEAP-010 study will not be met.


Kennedy Ferruggia

Latest:

Retinoic Acid, Vitamin A Demonstrates Role in Regulating Hair Follicles and Epidermal Stem Cells

In vitro studies demonstrated that retinoic acid aids stem cells in transitioning away from a state of flexibility in wound healing.


Howard Rogers, MD, PhD, FACMS

Latest:

Looking Ahead to the 2023 ACMS Meeting

The ACMS president and scientific program chair share opportunities to discover innovations in Mohs surgery during this weekend’s meeting.






Christopher G. Bunick, MD, PhD

Latest:

Rademikibart Differentiates From Dupilumab With Optimized IL-4Rα Inhibition and Enhanced Binding Stability

Christopher Bunick, MD, PhD, highlights rademikibart's next-generation efficacy, showing stronger IL-4Rα binding affinity in atopic dermatitis and asthma.


Brian Iriye, MD

Latest:

Considering consumerism in health care

Patients’ ability to choose can affect your practice.

© 2024 MJH Life Sciences

All rights reserved.